# Hanmi Pharmaceutical co., ltd.

Organization · id `cardio:org-hanmi-pharmaceutical-co-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Hanmi+Pharmaceutical+co.%2C+ltd.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.

## Technical summary

Sponsor class other. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Hanmi Pharmaceutical co., ltd.
- Sponsor class: OTHER

## Connected pages

- Sponsors: Korean Multicenter Randomized Controlled Trial (RCT) of Pidogul for Patients With Coronary Stenting (`cardio:ct-nct01584791`)
- Sponsors: Randomized Controlled Trial of Moderate-Intensity Rosuvastatin With Ezetimibe Combination Therapy Versus High-Intensity Rosuvastatin on Progression of Coronary Atherosclerotic Plaque (`cardio:ct-nct03169985`)
- Sponsors: Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) (`cardio:ct-nct05845489`)
- Sponsors: Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization (`cardio:ct-nct06767345`)
- Sponsors: Early Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome (`cardio:ct-nct07799779`)

## Provenance

Content hash: de3e3db6999981b22f88fa9a6914a17d64792c0cc5f5eeca33b09e4a7815afd2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
